Fecal Calprotectin Testing Market Players:
- Exelixis Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
- Abbexa Limited
- Bioserv Diagnostics Gmbh
- Epitope Diagnostics, Inc.
- LifeSpan BioSciences, Inc.
- RayBiotech, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of fecal calprotectin testing is evaluated at USD 6 billion.
The global fecal calprotectin testing market size was worth around USD 5.45 billion in 2025 and is set to register a CAGR of more than 11.2%, exceeding USD 15.76 billion revenue by 2035.
North America fecal calprotectin testing market will dominate over 45.7% share by 2035, fueled by high colorectal disease rates and a robust healthcare network.
Key players in the market include Exelixis Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc.
